Tidskriften the British Journal of Cancer

NEW STUDY. The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug include those with moderate to severe psoriasis; but in this particular patient group, a risk increase was only observed for basal cell carcinoma.  The study, based on Danish health care registers, was a result of a research…